SRPT - Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years | Benzinga
Sarepta Therapeutics (NASDAQ:SRPT) has outperformed the market over the past 10 years by 7.68% on an annualized basis producing an average annual return of 18.37%. Currently, Sarepta Therapeutics has a market capitalization of $15.43 billion.
Buying $1000 In SRPT: If ...